Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
Issue: Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue
Page(s): 346-349
Download in electronic PDF format for $75
Abstract: The purpose of this study was to assess the compatibility and stability of drugs commonly found in antibiotic lock solutions (cefotaxime 10 mg/mL plus heparin 5000 IU/mL, vancomycin 25 mcg/mL plus heparin 10 IU/mL, and vancomycin 25 mcg/mL plus ciprofloxacin 2 mg/mL plus heparin 10 IU/ mL). Antibiotic lock solutions under investigation were generated in triplicate from pooled starting samples and maintained at 4°C, 27°C, and 40°C. The antibiotic lock solutions were assessed at various time intervals for chemical stability (specified as retaining greater than 90% of initial drug via high-performance liquid chromatographic analysis) and physical stability (specified as solution free of visible precipitates). Antibiotic lock solutions containing cefotaxime plus heparin remained chemically and physically stable at 4°C throughout the study period. However, samples maintained at higher temperatures had no physical instability but underwent significant chemical degradation as early as 24 hours after the beginning of
Related Keywords:
cefotaxime, vancomycin, ciprofloxacin, antibiotic lock solutions, stability, compatibility, heparin
Related Categories:
PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Baker Daniel S, Waldrop Bruce, Arnold John
|
Jul/Aug 2010
Pg. 346-349
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
|
Nov/Dec 2022
Pg. 522-526
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
|
May/Jun 2020
Pg. 238-241
|
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley, Patel Jalpa
|
May/Jun 2020
Pg. 242-245
|
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Jul/Aug 2016
Pg. 347-350
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
|
Sep/Oct 2008
Pg. 456-459
|
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs
Allen Loyd V Jr, Stiles M Lou
|
Mar/Apr 1997
Pg. 123-124
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016
Pg. 159-163
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
|
Jul/Aug 2022
Pg. 330-335
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 508
|
Vancomycin HCl and Heparin Sodium Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 60
|
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Quay Irene, Tan Edward
|
Jul/Aug 2001
Pg. 323-324
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Stability of Vancomycin in SyrSpend SF
Whaley Paul A, Voudrie Mark A II
|
Mar/Apr 2012
Pg. 167-169
|
Return to Top |